Sign In
Buy BAYRY
$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Cramer's Mad Dash: Bayer AG
10:41am, Monday, 20'th Nov 2023
CNBC's Jim Cramer delivers his daily Mad Dash.
Bayer shares plunge to a near two-decade low after blood thinner trial failure
09:11am, Monday, 20'th Nov 2023
Bayer AG (ETR:BAYN, OTC:BAYZF), the German pharmaceutical giant, has seen its shares tank more than 20% to a near 18-year low following the failure of a key drug trial and legal challenges in the Un
Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted
06:33am, Monday, 20'th Nov 2023
Bayer lost a fifth of its market value at one point Monday, after the German pharmaceutical and agricultural group said it had ended a late-stage test for the anti-thrombotic drug asundexian due to a
Bayer Stock Drops to Lowest Since 2009 as Blood Thinner Trial Fails
05:49am, Monday, 20'th Nov 2023
Bayer says late-stage testing of a drug called asundexian used to treat heart disease would be stopped because it didn't appear to be effective.
Bayer cancels asundexian phase III study program
07:18pm, Sunday, 19'th Nov 2023
Germany's Bayer AG said on Sunday it is cancelling a phase III study program to investigate the efficacy and safety of asundexian, an oral Factor XIa (FXIa) inhibitor.
Bayer ordered to pay $1.56 billion in latest US trial loss over Roundup weedkiller
11:35am, Sunday, 19'th Nov 2023
A Missouri jury ordered Bayer to pay $1.56 billion to four plaintiffs who claimed the company's Roundup weedkiller caused injuries including cancer, a verdict that could intensify investor pressure on
Bayer Told to Pay $1.56 Billion After Losing Roundup Case
07:43pm, Saturday, 18'th Nov 2023
A Missouri jury found in favor of plaintiffs as verdicts seesaw in trials involving the fertilizer.
Bayer recalls one lot of cancer drug Vitrakvi
05:52pm, Friday, 17'th Nov 2023
Bayer said on Friday it was voluntarily recalling one lot of its cancer drug Vitrakvi due to the presence of microbial contamination.
Bayer withdraws follicular lymphoma drug after further trial fails
10:32am, Monday, 13'th Nov 2023
Bayer on Monday said it would voluntarily withdraw the follicular lymphoma drug Aliqopa, also known as copanlisib, from the U.S. market after a trial designed to confirm its benefit did not show the d
European regulator endorses high-dose version of Bayer eye drug Eylea
09:10am, Friday, 10'th Nov 2023
Bayer said on Friday that the European Medicines Agency recommended approval of a higher dose version of eye drug Eylea for treatment of a leading cause of blindness among the elderly, stepping up com
Bayer's (BAYRY) Q3 Earnings and Revenues Miss Estimates
01:31pm, Wednesday, 08'th Nov 2023
Bayer (BAYRY) reports weaker-than-expected third-quarter 2023 results. Management maintains its 2023 outlook.
Bayer Aktiengesellschaft (BAYZF) Q3 2023 Earnings Call Transcript
10:19am, Wednesday, 08'th Nov 2023
Bayer Aktiengesellschaft (OTCPK:BAYZF) Q3 2023 Earnings Conference Call November 8, 2023 8:00 AM ET Company Participants Jost Reinhard - Senior Vice President & Head-Investor Relations Bill Anderson -
Bayer ordered to pay $332 mln in Roundup cancer trial -Law.com
07:46pm, Tuesday, 31'st Oct 2023
A California jury found Bayer liable in a case brought by a man who claimed his cancer was due to exposure to the company's Roundup weed killer, and ordered it to pay $332 million in damages, Law.com
New Strong Sell Stocks for October 17th
09:01am, Tuesday, 17'th Oct 2023
BAYYR, EDAP and FWRD have been added to the Zacks Rank #5 (Strong Sell) List on October 17, 2023.
Gene therapy, Parkinson's disease, and food science: Bayer U.S. discusses the latest technology
09:00am, Sunday, 15'th Oct 2023
Most Americans know Bayer (BAYN.DE) for its over-the-counter medicines like Aleve and Claritin. But that's not all the company does.
